Levaquin: Potent Antibiotic for Severe Bacterial Infections

Levaquin

Levaquin

Price from 40.00 $
Product dosage: 250mg
Package (num)Per pillPriceBuy
30$1.70$51.12 (0%)🛒 Add to cart
60$1.50$102.23 $90.21 (12%)🛒 Add to cart
90$1.30$153.35 $117.27 (24%)🛒 Add to cart
120$1.15$204.47 $138.32 (32%)🛒 Add to cart
180$1.00$306.70 $180.41 (41%)🛒 Add to cart
270$0.90$460.05 $243.56 (47%)🛒 Add to cart
360
$0.87 Best per pill
$613.40 $313.72 (49%)🛒 Add to cart
Product dosage: 500mg
Package (num)Per pillPriceBuy
20$2.00$40.09 (0%)🛒 Add to cart
30$1.90$60.14 $57.13 (5%)🛒 Add to cart
60$1.80$120.27 $108.25 (10%)🛒 Add to cart
90$1.65$180.41 $148.34 (18%)🛒 Add to cart
120$1.50$240.55 $180.41 (25%)🛒 Add to cart
180$1.25$360.82 $225.52 (37%)🛒 Add to cart
270$1.13$541.24 $305.70 (44%)🛒 Add to cart
360
$1.03 Best per pill
$721.65 $370.85 (49%)🛒 Add to cart

Levaquin (levofloxacin) is a broad-spectrum fluoroquinolone antibiotic indicated for the treatment of adults with serious bacterial infections. It demonstrates excellent tissue penetration and bactericidal activity against a wide range of Gram-positive and Gram-negative pathogens. This medication is reserved for cases where first-line antibiotics have failed or are inappropriate due to resistance patterns or patient factors. Proper diagnosis and antimicrobial stewardship are essential when considering Levaquin therapy.

Features

  • Contains levofloxacin, the L-isomer of ofloxacin with enhanced antibacterial activity
  • Available in oral tablets (250mg, 500mg, 750mg) and intravenous formulations
  • Broad-spectrum coverage including Pseudomonas aeruginosa and atypical pathogens
  • Once-daily dosing regimen for improved patient compliance
  • Excellent bioavailability with approximately 99% oral absorption

Benefits

  • Effective against multidrug-resistant organisms where other antibiotics fail
  • Rapid bactericidal action reduces bacterial load quickly
  • Comprehensive coverage of both typical and atypical respiratory pathogens
  • Convenient once-daily dosing improves treatment adherence
  • Proven efficacy in complicated urinary tract and intra-abdominal infections
  • Well-established safety profile when used appropriately in indicated populations

Common use

Levaquin is approved for the treatment of adults with:

  • Community-acquired pneumonia (including multidrug-resistant Streptococcus pneumoniae)
  • Complicated urinary tract infections, including pyelonephritis
  • Acute bacterial exacerbation of chronic bronchitis
  • Acute bacterial sinusitis
  • Complicated skin and skin structure infections
  • Chronic bacterial prostatitis
  • Inhalational anthrax (post-exposure)
  • Plague

Dosage and direction

Dosage varies based on infection type and severity:

  • Community-acquired pneumonia: 500mg once daily for 7-14 days
  • Complicated UTI/acute pyelonephritis: 250mg once daily for 10 days
  • Complicated skin infections: 750mg once daily for 7-14 days
  • Chronic bacterial prostatitis: 500mg once daily for 28 days
  • IV to oral transition: May switch when clinically appropriate
  • Renal impairment: Dosage adjustment required for CrCl <50 mL/min
  • Administration: Take with or without food, with a full glass of water

Precautions

  • Reserve use for infections proven or strongly suspected to be caused by susceptible bacteria
  • Discontinue immediately if signs of tendon inflammation or rupture occur
  • Monitor for peripheral neuropathy; discontinue if symptoms develop
  • Use with caution in patients with CNS disorders or risk factors for seizures
  • May exacerbate muscle weakness in patients with myasthenia gravis
  • Avoid excessive sunlight or artificial UV light due to photosensitivity risk
  • Monitor blood glucose levels in diabetic patients
  • Not recommended for uncomplicated infections when other alternatives exist

Contraindications

  • Known hypersensitivity to levofloxacin or other quinolone antibiotics
  • History of tendon disorders related to fluoroquinolone use
  • Patients with myasthenia gravis (may exacerbate muscle weakness)
  • Concomitant administration with tizanidine
  • Pediatric patients (except for inhalational anthrax post-exposure)
  • Pregnancy and breastfeeding (unless potential benefit justifies potential risk)

Possible side effect

Common adverse reactions (≥1%):

  • Nausea, diarrhea, headache, insomnia
  • Constipation, dizziness, abdominal pain

Serious adverse reactions:

  • Tendonitis and tendon rupture (may occur during or after therapy)
  • Peripheral neuropathy (may be irreversible)
  • CNS effects (seizures, increased intracranial pressure, anxiety)
  • Exacerbation of myasthenia gravis
  • QT interval prolongation and arrhythmias
  • Hepatotoxicity (elevated liver enzymes, hepatitis)
  • Blood glucose disturbances
  • Photosensitivity/phototoxicity reactions
  • Clostridium difficile-associated diarrhea

Drug interaction

Significant interactions include:

  • Antacids, sucralfate, metal cations (aluminum, magnesium, calcium, iron, zinc): significantly reduce absorption (separate by at least 2 hours)
  • Warfarin: enhanced anticoagulant effect (monitor INR closely)
  • NSAIDs: increased risk of CNS stimulation and seizures
  • Antiarrhythmics (Class IA, III): increased QT prolongation risk
  • Corticosteroids: increased risk of tendon rupture
  • Oral hypoglycemics: may affect blood glucose control
  • Theophylline: increased theophylline levels (monitor concentrations)

Missed dose

  • Take the missed dose as soon as remembered, unless it is almost time for the next scheduled dose
  • Do not double the dose to make up for a missed dose
  • Maintain regular dosing intervals to ensure consistent antibiotic levels
  • Contact healthcare provider if multiple doses are missed for guidance

Overdose

Symptoms may include:

  • CNS excitation (seizures, tremors, confusion)
  • QT prolongation and ventricular arrhythmias
  • Gastrointestinal distress (nausea, vomiting)
  • Renal and hepatic impairment

Management:

  • Supportive care with ECG monitoring
  • Seizure control with benzodiazepines
  • Hemodialysis removes approximately 10% of dose
  • No specific antidote available
  • Contact poison control center for latest management guidelines

Storage

  • Store at room temperature (15-30°C or 59-86°F)
  • Protect from light and moisture
  • Keep in original container with lid tightly closed
  • Do not store in bathroom or damp areas
  • Keep out of reach of children and pets
  • Do not use after expiration date
  • Properly dispose of unused medication

Disclaimer

This information is for educational purposes only and does not constitute medical advice. Levaquin is a prescription medication that should only be used under the supervision of a qualified healthcare professional. The healthcare provider should consider official prescribing information and individual patient factors before prescribing. Patients should not self-medicate or adjust dosage without medical consultation. Report any adverse reactions to healthcare provider immediately.

Reviews

“Levaquin proved effective in treating our hospital-acquired pneumonia cases resistant to first-line agents. The once-daily dosing simplified our antimicrobial stewardship protocol.” - Infectious Disease Specialist, 12 years experience

“While potent, we reserve Levaquin for cases where benefits clearly outweigh risks. The tendon toxicity concerns require careful patient selection and monitoring.” - Clinical Pharmacist, Academic Medical Center

“Excellent tissue penetration makes it valuable for prostatic infections. However, we always consider alternative agents first due to safety profile concerns.” - Urologist, 15 years practice